Cargando…
CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer
The aggressive nature and metastatic potential of pancreatic cancer (PC) results in poor prognosis and high mortality. A better understanding of the underlying biology of PC and the ability of tumor cells to spread to distant sites is needed to advance the treatment of PC. The chemokine receptor CXC...
Autores principales: | Gardner, Kirby P., Tsai, Susan, Aldakkak, Mohammed, Gironda, Stephen, Adams, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903256/ https://www.ncbi.nlm.nih.gov/pubmed/35259193 http://dx.doi.org/10.1371/journal.pone.0264763 |
Ejemplares similares
-
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes
por: Gardner, Kirby P., et al.
Publicado: (2021) -
Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer
por: Kasabwala, Dimpal M., et al.
Publicado: (2022) -
Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation-resistant pancreatic cancer
por: Kato, Tomokatsu, et al.
Publicado: (2022) -
Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020) -
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)